Matt Abernethy

Affiliations

  • at Fate Therapeutics Inc (FATE), 2025-05-30
  • Chief Financial Officer at Neurocrine Biosciences Inc (NBIX), 2025-02-14
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
NBIX $116.87 1,206 $140,943.77 35,810 2025-02-13 Filing
NBIX $116.85 1,352 $157,979.44 34,775 2025-02-13 Filing
NBIX $118.27 980 $115,908.52 33,561 2025-02-10 Filing
NBIX $152.87 1,283 $196,135.80 32,681 2025-01-31 Filing
NBIX $150.38 14,100 $2,120,346.72 31,528 2024-08-13 Filing